Long
IDERA PHARAMA
IDERA :
Croissance de 72% p/a - deux traitement anti-cancéreux du colon en cours phase 2 & 3.
IDERA:
Growth of 72% p / a - Two anti-cancer treatments for the colon in phase 2 & 3
finance.yahoo.com/news/idera-pharmaceuticals-inc-nasdaq-idra-083136044.html
Croissance de 72% p/a - deux traitement anti-cancéreux du colon en cours phase 2 & 3.
IDERA:
Growth of 72% p / a - Two anti-cancer treatments for the colon in phase 2 & 3
finance.yahoo.com/news/idera-pharmaceuticals-inc-nasdaq-idra-083136044.html
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.